Voriconazole Film-Coated Tablets: To Split Them or Not?

  • Zahra Sahraei Department of Clinical pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences.
  • Saghar Barati Mail Department of Clinical pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences.
Keywords:
No Keywords, No Keywords No Keywords

Abstract

No Abstract No Abstract No Abstract No Abstract No Abstract

References

1. Mangal N, Hamadeh IS, Arwood MJ, et al. Optimization of voriconazole therapy for the treatment of invasive fungal infections in adults. Clin Pharmacol Ther 2018;104(5):957-65.
2. Vfend (Voriconazole) Tablets, Oral Suspension, and IV [package insert]. New York: Pfizier, 2011.
3. Purkins L, Wood N, Ghahramani P, Greenhalgh K, Allen MJ, Kleinermans D. Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens. Antimicrob Agents Chemother 2002;46(8):2546-53.
4. Eldar D. Design, formulation and manufacture of film-coated drug products [2017]. Available from: https://www.europeanpharmaceuticalreview.com/article/68115/design-formulation-manufacture/.
5. Dodds Ashley ES, Zaas AK, Fang AF, Damle B, Perfect JR. Comparative pharmacokinetics of voriconazole administered orally as either crushed or whole tablets. Antimicrob Agents Chemother 2007;51(3):877-80.
6. Practice Ifsm. oral dosage forms that should not be crushed [2020 [Available from: https://www.ismp.org/recommendations/do-not-crush.
Published
2020-09-28
How to Cite
1.
Sahraei Z, Barati S. Voriconazole Film-Coated Tablets: To Split Them or Not?. J Pharm Care. 8(3):148-149.
Section
Letter to the Editor